Certified by Founder
Lodge
Genezen
start up
United States
- Genezen
- 03/11/2023
- Unknown
- $18,500,000
Founded in Indianapolis in 2014, Genezen is focused on supporting the demands of the current and future gene and cell therapy manufacturing market worldwide— making viral vector production accessible to both early-stage, growth-oriented companies and established industry leaders. Genezen offers early-phase process development, GMP lentiviral vector production, retroviral vector production, and analytical testing services, building on the company's expansive knowledge and experience in the industry and working with the nation's leading institutions. For more information, or to learn more about services offered in Genezen's new cGMP facility, please visit our website: www.genezen.com
- Industry Biotechnology Research
- Website https://www.genezen.com/
- LinkedIn https://www.linkedin.com/company/genezen-laboratories/about/
Ultralight | $9,300,000 | (Apr 21, 2026)
Sage Haven | $3,000,000 | (Apr 21, 2026)
CREAO AI | $10,000,000 | (Apr 21, 2026)
ViewsML | $4,900,000 | (Apr 21, 2026)
Antioch | $8,500,000 | (Apr 21, 2026)
Wavelet Medical | $7,000,000 | (Apr 21, 2026)
Rivan Industries | $34,000,000 | (Apr 21, 2026)
urfuture | $2,299,785 | (Apr 21, 2026)
TraqCheck | $8,000,000 | (Apr 21, 2026)
Giggles | $1,000,000 | (Apr 21, 2026)
brainjo GmbH | $2,356,020 | (Apr 21, 2026)
Coral(US) | $12,500,000 | (Apr 21, 2026)